Virtual Library
Start Your Search
- Virtual Library Home
- IASLC Library
- Explore Event
-
WCLC 2022
2022 World Conference on Lung Cancer
As an IASLC member, you can enjoy complimentary access to the presentations from the World Conference on Lung Cancer 2022. If you participated in the conference, kindly utilize the code "WCLC2022ACCESSFULL" to enter the virtual meeting and access the recordings.
Presentation Date(s):- August 6 - 9, 2022
- Total Presentations: 2015
-
+
ES38 - Optimising the Management of SCLC and Neuroendocrine Tumours
- Type: Education Session
- Track: Small Cell Lung Cancer and Neuro-Endocrine Tumors
- Presentations: 8
- Moderators:Feng-Ming Spring Kong
- Coordinates: 8/09/2022, 14:30 - 15:30, Strauss 1/2
-
+
ES38.01 - Session Introduction
14:30 - 14:31 | Author(s): Feng-Ming Spring Kong
- Abstract
Loading... -
+
Session Moderator
14:30 - 14:31 | Author(s): Feng-Ming Spring Kong
- Abstract
Loading... -
+
ES38.02 - Session Introduction
14:31 - 14:32 | Author(s): Nevena M Secen
- Abstract
Loading... -
+
ES38.03 - What’s the Best Management for CNS Metastases in the Era of IO?
14:32 - 14:47 | Author(s): Inga Grills
- Abstract
Loading... -
+
ES38.04 - Treatment of Relapsed/Refractory SCLC: Old and New Drugs
14:47 - 15:02 | Author(s): Charles M Rudin
- Abstract
Loading... -
+
ES38.05 - How Should We Treat Pulmonary Large-Cell Neuroendocrine Carcinomas?
15:02 - 15:17 | Author(s): Andrea Ardizzoni
- Abstract
Loading... -
+
ES38.06 - Live Q&A
15:17 - 15:30
- Abstract
Loading... -
+
Session Moderator
15:17 - 15:30 | Author(s): Nevena M Secen
- Abstract
Loading...
-
+
ES39 - Role of Novel Biomarkers and Technologies in Optimal Diagnosis and Disease Management: Focus on Liquid Biopsies And Advanced Tissue Diagnostics
- Type: Education Session
- Track: Tumor Biology and Biomarkers
- Presentations: 9
- Moderators:Umberto Malapelle
- Coordinates: 8/09/2022, 14:30 - 15:30, Lehar 1
-
+
ES39.01 - Session Introduction
14:30 - 14:31 | Author(s): Umberto Malapelle
- Abstract
Loading... -
+
ES39.02 - Session Introduction
14:31 - 14:32 | Author(s): Christian Diego Rolfo
- Abstract
Loading... -
+
ES39.03 - Advances and Role of CTCs for Lung Cancer Diagnosis and Treatment (Early and Advanced: NSCLC and SCLC)
14:32 - 14:44 | Author(s): Caroline Dive
- Abstract
Loading... -
+
ES39.04 - Optimal Use of ctDNA Analysis Lung Cancer Diagnosis, Response Assessment and Monitoring
14:44 - 14:56 | Author(s): Christian Diego Rolfo
- Abstract
Loading... -
+
ES39.05 - Biomarker Analysis of the Tumor Microenvironment and Tumor-Immune Cell Interactions Using High-Plex Spatial and Single-Cell Studies
14:56 - 15:08 | Author(s): Junko Tanizaki
- Abstract
Loading... -
+
ES39.06 - Advanced Tumor-Based and Circulating Diagnositics in Early Stage Disease
15:08 - 15:20 | Author(s): Lillian Siu
- Abstract
Loading... -
+
ES39.07 - Live Q&A
15:20 - 15:30
- Abstract
Loading... -
+
Session Moderator
15:20 - 15:30 | Author(s): Umberto Malapelle
- Abstract
Loading... -
+
Session Moderator
15:20 - 15:30 | Author(s): Christian Diego Rolfo
- Abstract
Loading...
-
+
MA14 - Palliative and Supportive Care - The Forgotten Trade
- Type: Mini Oral
- Track: Palliative and Supportive Care
- Presentations: 13
- Moderators:Maria Werner-Wasik
- Coordinates: 8/09/2022, 14:30 - 15:30, Strauss 3
-
+
MA14.01 - Session Introduction
14:30 - 14:31 | Author(s): Maria Werner-Wasik
- Abstract
Loading... -
+
MA14.02 - Session Introduction
14:31 - 14:32 | Author(s): Satoko Kono
- Abstract
Loading... -
+
MA14.03 - Effect of Mirtazapine on Energy Intake in Patients with Anorexia Associated with NSCLC
14:32 - 14:37 | Author(s): Oscar Arrieta
- Abstract
Loading... -
+
MA14.04 - Sexual Health Assessment in Women with Lung Cancer (SHAWL) Study
14:37 - 14:42 | Author(s): Narjust Florez (Duma)
- Abstract
Loading... -
+
MA14.05 - A Double-blind Phase III Trial of Denosumab Biosimilar QL1206 vs Denosumab in Bone Metastatic Tumor: Lung Cancer Cohort Data
14:42 - 14:47 | Author(s): Yan Huang
- Abstract
Loading... -
+
MA14.06 - Discussant
14:47 - 14:57 | Author(s): Karin Dieckmann
- Abstract
Loading... -
+
Session Moderator
14:47 - 14:57 | Author(s): Maria Werner-Wasik
- Abstract
Loading... -
+
Session Moderator
14:47 - 14:57 | Author(s): Satoko Kono
- Abstract
Loading... -
+
MA14.07 - The Use of Medical Cannabis Concomitantly with Immune-Check Point Inhibitors (ICI) in Non Small Cell Lung Cancer (NSCLC): A Sigh of Relief?
14:57 - 15:02 | Author(s): Barliz Waissengrin
- Abstract
Loading... -
+
MA14.08 - Longitudinal Symptoms and Health Utility Scores (HUS) in Patients Receiving PD-1 Inhibitors for Metastatic NSCLC
15:02 - 15:07 | Author(s): Christopher Poletes
- Abstract
Loading... -
+
MA14.09 - Lower Paraspinous Muscle Index at First Thoracentesis is Associated with Poor Survival in Non-Small Cell Lung Cancer
15:07 - 15:12 | Author(s): Austin Meggyesy
- Abstract
Loading... -
+
MA14.10 - Discussant
15:12 - 15:22 | Author(s): Devayani Niyogi
- Abstract
Loading... -
+
MA14.11 - Live Q&A
15:22 - 15:30
- Abstract
Loading...
-
+
OA15 - Patient Selection in Advanced NSCLC Immunotherapy
- Type: Oral
- Track: Metastatic Non-small Cell Lung Cancer - Immunotherapy
- Presentations: 10
- Moderators:Pilar Garrido
- Coordinates: 8/09/2022, 14:30 - 15:30, Hall C7
-
+
Session Moderator
14:32 - 00:00 | Author(s): Pilar Garrido
- Abstract
Loading... -
+
Session Moderator
14:32 - 00:00 | Author(s): António Araújo
- Abstract
Loading... -
+
OA15.01 - Session Introduction
14:30 - 14:31 | Author(s): Pilar Garrido
- Abstract
Loading... -
+
OA15.02 - Session Introduction
14:31 - 14:32 | Author(s): António Araújo
- Abstract
Loading... -
+
OA15.03 - Avelumab vs Chemotherapy for First-line Treatment of Advanced PD-L1+ NSCLC: Primary Analysis from JAVELIN Lung 100
14:32 - 14:42 | Author(s): Martin Reck
- Abstract
Loading... -
+
OA15.04 - Association Between KRAS/STK11/KEAP1 Mutations and Outcomes in POSEIDON: Durvalumab ± Tremelimumab + Chemotherapy in mNSCLC
14:42 - 14:52 | Author(s): Solange Peters
- Abstract
Loading... -
+
OA15.05 - HUDSON: An Open-Label, Multi-Drug, Biomarker-Directed Phase 2 Study in NSCLC Patients Who Progressed on Anti-PD-(L)1 Therapy
14:52 - 15:02 | Author(s): Benjamin Besse
- Abstract
Loading... -
+
OA15.06 - Pooled Analysis of Outcomes With Second-Course Pembrolizumab Across 5 Phase 3 Studies of Non-Small-Cell Lung Cancer
15:02 - 15:12 | Author(s): Delvys Rodriguez-Abreu
- Abstract
Loading... -
+
OA15.07 - Discussant
15:12 - 15:22 | Author(s): Puey Ling Chia
- Abstract
Loading... -
+
OA15.08 - Live Q&A
15:22 - 15:30
- Abstract
Loading...
-
+
PL05 - Closing Plenary 5: Access to Drugs (Live Streamed Session)
- Type: Plenary
- Track: N/A
- Presentations: 8
- Moderators:Yi-Long Wu
- Coordinates: 8/09/2022, 15:45 - 16:45, Hall C1
-
+
PL05.01 - Session Introduction
Author(s): Yi-Long Wu- Abstract
Loading... -
+
PL05.02 - Session Introduction
Author(s): Clarissa Mathias- Abstract
Loading... -
+
PL05.03 - How to Double Lung Cancer Survival within 5 Years
Author(s): Giorgio Scagliotti- Abstract
Loading... -
+
PL05.04 - Access to Drugs
Author(s): Nir Peled- Abstract
Loading... -
+
PL05.05 - Drug Development in the 21st Century
Author(s): Francesco Pignatti- Abstract
Loading... -
+
PL05.06 - Closing Remarks
- Abstract
Loading... -
+
Session Moderator
Author(s): Yi-Long Wu- Abstract
Loading... -
+
Session Moderator
Author(s): Clarissa Mathias- Abstract
Loading...
first
prev